top of page

Search Results

Results found for "G protein-coupled receptors"

  • Allosteric Binding Demystified: Smarter GPCR Drug Discovery

    of what’s inside this week’s Premium Edition: Industry insights:  Metabolic GPCRs in the spotlight; receptor Protect your pipeline:  Misinterpreting displacement curves in allosteric assays means discarding viable Avoid costly blind spots:  Discover how G protein stoichiometry can dictate whether your assay informs—or

  • From Multiplex to Models: Scaling Up GPCR Discovery in the Post-Silo Era

    .” — Tom Sakmar A Use Case for Every Angle Beyond RAMPs, this platform can study: Scaffold protein interactions Kotliar sums it up best: “We went from one receptor to many… and now, from many, we can go back to one

  • Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining

    Fluorescent ligands based on small molecules bind to the functional sites of receptors in live cells, This facilitates the study of receptor dynamics, ligand binding and signaling in real time. Specificity issues Some antibodies bind to shared epitopes across different proteins, which may lead , analyzing ligand-receptor interactions, which are not as detectable with antibodies. and CELT-483 for the hσ1/σ2 sigma receptor.

  • 📰 GPCR Weekly News, June 12 to 18, 2023

    GPCR Activation and Signaling Single transmembrane GPCR modulating proteins: neither single nor simple A unique melanocortin-4-receptor signaling profile for obesity-associated constitutively active variants GPCRs in Neuroscience Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production (June 28 - 30, 2023) NEW FREE Seminar Antibodies targeting Membrane Proteins - From Antigen to New Therapeutics

  • Adhesion GPCR Consortium Newsletter - May 2024

    the tethered agonist-dependent activities of all 33 aGPCRs in a suite of transcriptional reporter, G protein activation and B-arrestin recruitment assays. PMID: 38608683 The activation profile of different G proteins by ADGRL3 is shown using a collection of BAI1 is expressed in the afferent spiral ganglion neurons in the mouse cochlea where it localizes AMPA receptors

  • How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)

    Septerna begins first-in-human trial of SEP-631 for CSU; Maxion’s KnotBody® platform; a new angle on RGS protein Career opportunities:  Snapshot of roles spanning PhD entry points to senior translational pharmacology—Protein modulating its degradation (versus direct inhibition); selectivity frameworks for β₂ vs β₁ adrenergic receptors tp structural insights into cholesterol interactions in the active conformation of GLP‑1 receptor Terry's Eliminate fix/perm distortions:  Preserve receptor conformation and downstream signaling integrity.

  • Artificial intelligence – faster, smarter, cheaper GPCR drug discovery

    One major challenge is the identification of receptor subtype-selective ligands. In this context, BRS-3D was used to predict subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben, Kuang, Wang & Kong, 2016; Kuang, Feng, Hu, Wang, He & Kong, 2016). 5. Paremeters such as ligand affinity for the receptor (pKi), the ability of a ligand to induce or inhibit a cellular response (pEC50 or pIC50, respectively), and how long the ligand remains bound to the receptor

  • Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...

    molecular docking was applied to valid the important interactions between the ingredients and the target protein herb-component-target" network indicated that the ingredients of Girinimbin, Gomisin B and Asarone, and the protein highlighted the most significant pathways associated with depression treatment, including neuroactive ligand-receptor HTR, DR, ADRA, AR, ESR, NR3C1) and modulate the activation of multiple pathways (Neuroactive ligand -receptor

  • TAS2R supports odontoblastic differentiation of human dental pulp stem cells in the inflammatory...

    The G protein and intracellular Ca2+ were detected, respectively, by qPCR and Fluo-4AM Ca2+ fluorescent

  • Roles of Focal Adhesion Kinase PTK2 and Integrin αIIbβ3 Signaling in Collagen- and GPVI-Dependent...

    GPVI-Dependent Thrombus Formation under Shear "Glycoprotein (GP)VI and integrin αIIbβ3 are key signaling receptors Here, we focused on disclosing the integrin-dependent roles of focal adhesion kinase (protein tyrosine kinase 2, PTK2), the shear-dependent collagen receptor GPR56 (ADGRG1 gene), and calcium and integrin-binding protein 1 (CIB1).

  • 📰 GPCR Weekly News, August 7 to 13, 2023

    GPCR Activation and Signaling Tail engagement of arrestin at the glucagon receptorprotein signaling bias at 5-HT1A receptor GPCRs in Cardiology, Endocrinology, and Taste Gβγ-SNAP25 exocytotic brake removal enhances insulin action, promotes adipocyte browning, and protects against diet-induced obesity GPCRs in Neuroscience The neuropeptide receptor npr-38 regulates avoidance and stress-induced sleep in Caenorhabditis November 20 -23, 2023) Structure, Mechanism, and Drug Interactions of GPCRs, Ion Channels, and Transport Proteins

  • How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

    For a field that depends on understanding where receptors actually are — and how many are available at Receptors internalize, traffic, recycle, and degrade. cell biologists — all working toward the same goal: building better tools for visualizing cell-surface proteins The work now stretches far beyond a single receptor. They’re also performing increasingly complex imaging experiments that capture receptor dynamics in intact

  • Molecular creativity in drug discovery

    Breakthroughs this week:  Orphan receptor GPRC5B in neurogenesis; Septerna’s pill-based weight-loss strategy Must-read publications:  Emerging targets, signaling dynamics, and acid-sensing receptors in disease. Key Insights: • Receptor Localization Matters : Protein complexes pre-assemble at membranes, altering

  • Assay Volume Control: Your GPCR Drug Discovery Power Lever

    , leptin signaling, and inflammation-linked GPCRs — and curated roles in computational and membrane protein – Assay Volume Control in GPCR Drug Discovery This week in Terry’s Corner, you’ll learn how dialing receptor expression/coupling up or down reveals hidden partial agonism, “silent” agonism, inverse agonism, and Your membership gives you:   Proven   frameworks  for real-world GPCR drug discovery Flexible , on-demand

  • New Resources in GPCRdb

    Gáspár Pándy-Szekeres ) will present and demonstrate the newest resources of the GPCRdb: 1) the new G protein resources and 2) the structural analysis platform.

  • GPCR Collaboration: From Models to Medicine

    While experimentalists struggled for months with crystallography, he could pull a clean protein structure from the Protein Data Bank in a single afternoon and move on. For receptor assays and the biological interpretation of ligands, he relies on a network of collaborators Structural biologists may capture snapshots of receptor conformations, but lack large-scale screening

  • Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota..

    Here, we show that the gut IEL GLP-1 receptor (GLP-1R) is not required for enteroendocrine L cell GLP mediated by the suppression of gut IEL effector functions linked to the dampening of proximal T cell receptor signaling in a protein-kinase-A-dependent manner.

  • Platelets in the NETworks interweaving inflammation and thrombosis

    The surface expression of pattern recognition receptors, such as TLR2 and TLR4, provides platelets with Platelet α-granules contain microbicidal proteins, chemokines and growth factors, which upon release is characterized by neutrophils expelling chromatin fibres decorated with histones and antimicrobial proteins The negatively charged DNA within NETs provides a procoagulant surface, and in particular NET-derived proteins

  • Understanding Enzyme Inhibition In GPCR Discovery Programs

    discovery This Week’s GPCR Intelligence: Every drug you design will meet an enzyme before it meets its receptor Enzyme Inhibition Shapes Every Discovery Program Every molecule meets an enzyme before it ever meets its receptor Suntans, and GPCR Micro-Domains Two recent papers connect ciliary signaling, opsins, and melanocortin receptors in appetite circuits and MCR1 in melanocytes highlights the power of localized cAMP and ion channel coupling Localized cAMP and channel coupling as levers for phenotype. New tools, new questions.  

  • How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision

    Breakthroughs this week:  Why Everyone’s Talking About Metabolic GPCRs; GPS for proteins: Tracking the motions of cell receptors; A Better Way to Treat Obesity; Unlocking the pharmacological potential of Industry insights:  Metabolic GPCRs climbing the spotlight; new tools tracking receptor motion; obesity Must-read publications:  A structural modeling study revealing non-canonical mechanisms of chemokine-driven receptor This is where the real conversations begin—made possible with the support of NIS, Proteos, and Axxam  

  • How System-Level GPCR Thinking Prevents Discovery Failures

    Insights That Prevent Real Drug Discovery Failures Discovery collapses when teams assume stable, linear, receptor-to-response ’s AMA made the central point unmistakable: GPCR systems constantly reshape ligand behavior through coupling efficiency, receptor density, local signaling architecture, and physiological feedback loops. Johannes Broichhagen Reliable imaging tools change how researchers see receptor behavior. antibodies fail How parallel synthesis& testing accelerates probe optimization How surface-exposed receptor

  • Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today

    Passive diffusion dominates for many small molecules, but protein binding, transporters, and tissue architecture vivo correlation depends on scaling assumptions and controls CYP inhibition, transporter assays, protein Even perfect receptor pharmacology fails if target-site exposure is insufficient or transient .

  • Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...

    Somatostatin receptors (SSTs) are class A GPCRs abundantly expressed in pituitary tumors where they represent The cytoskeletal protein filamin A (FLNA) directly interacts with both somatostatin receptor type 2 ( octreotide or pasireotide may play modulatory effects and whether FLNA may participate to this level of receptor On the contrary, in M2 cells, octreotide failed to internalize both receptors whereas pasireotide promoted robust receptor internalization at shorter times than in A7 cells.

  • The Truth About GPCR Product Launches: Years in the Making

    Functional assays for GPCRs—especially Gq-coupled receptors—were notoriously messy. Calcium flux? By covalently attaching the probe to FLAG-tagged receptors or using labeled antibodies, they created Their “aha” moment came when they ran a dose-response with Exendin-4 on GLP-1 receptors—and saw clean It reflects decades of foundational R&D—from the fluorescent probes of Cisbio’s early days to the receptor-targeting

  • How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program

    Breakthroughs this week: Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling; Proximity-Dependent Proteomics Upcoming events:  Get details on the "neuroGPCR" symposium focusing on receptor signaling and a platform , a case for functionally Gs protein-selective GPCRs, and new methods for detecting simultaneous ligand down with Alessandro Nicoli, from the Technical University of Munich, to discuss his work on olfactory receptors Discover how breakthroughs like AlphaFold are making previously "undruggable" targets, like olfactory receptors

  • Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids

    September 2022 "The Smoothened receptor (SMO, a 7 pass transmembrane domain, Class F GPCR family protein In the absence of HH signaling, SMO is inhibited by Patched 1 (PTC1; a 12 pass transmembrane domain protein

  • Target Residence Time: The Hidden Driver of In Vivo Efficacy

    tissues like tumors slows offset and improves therapeutic window ✅ Examples of how rebinding in dense receptor Diffusion, Rebinding, and Receptor Density: The In Vivo Edge This lecture shows how tissue architecture And when receptors are dense (like GPCRs on membranes), this rebinding hits the collisional limit , where Subscribe to The Kenakin Brief today ➤ #TargetResidenceTime #DrugBindingKinetics #PKPDdissociation #ReceptorPharmacology

  • PI(4,5)P 2-stimulated positive feedback drives the recruitment of Dishevelled to Frizzled in Wnt-β-c

    September 2022 "In the Wnt-β-catenin pathway, Wnt binding to Frizzled (Fzd) and LRP5 or LRP6 (LRP5/6) co-receptors Using purified Fzd proteins reconstituted in lipid nanodiscs, we investigated the factors that promote

  • When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue

    Could they map receptor heterogeneity across the islet? Could they quantify plasma membrane vs. intracellular receptor pools? The tools didn’t simply visualize receptors. mapping Super-resolution imaging of receptor nanodomains AI-assisted probe design Multi-receptor visualization Not one receptor at a time. Not one color. Not one imaging depth.

  • 📰 GPCR Weekly News, October 23 to 29, 2023

    GPCR Activation and Signaling The GPCR adaptor protein Norbin regulates S1PR1 trafficking and the morphology , cell cycle and survival of PC12 cells GLP-1 and GIP receptors signal through distinct β-arrestin 2- mobilization when combined with propranolol Discovery of 3-Phenyl Indazole-Based Novel Chemokine-like Receptor

bottom of page